Acceptance and Commitment Therapy With Vestibular Rehabilitation for Chronic Dizziness
NCT ID: NCT03029949
Last Updated: 2023-11-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
66 participants
INTERVENTIONAL
2017-04-25
2021-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison Between Traditional Vestibular Rehabilitation Therapy And Virtual Reality In Management Of Patients With Chronic Dizziness
NCT07210840
Effects of a Vestibular Rehabilitation Maneuver
NCT01080430
Internet-based Self-help Program for Vestibular Rehabilitation in Chronic Dizziness
NCT04458376
Implementation of Evidence-Based Practice for Dizziness
NCT05634902
Vestibular Physical Therapy for People With Alzheimer Disease
NCT03887923
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ACT with VR
acceptance and commitment therapy with vestibular rehabilitation in addition to clinical management
ACT with VR
6 weekly 120-minute group sessions of acceptance and commitment therapy with vestibular rehabilitation, and brief (approximately 15 minute) individual follow-up sessions at 1 and 3 months after the group treatment
clinical management
clinical management and pharmacotherapy as usual for chronic dizziness
Self-treatment VR
self-treatment vestibular rehabilitation in addition to clinical management
self-treatment VR
booklet written on vestibular rehabilitation for self-treatment
clinical management
clinical management and pharmacotherapy as usual for chronic dizziness
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ACT with VR
6 weekly 120-minute group sessions of acceptance and commitment therapy with vestibular rehabilitation, and brief (approximately 15 minute) individual follow-up sessions at 1 and 3 months after the group treatment
self-treatment VR
booklet written on vestibular rehabilitation for self-treatment
clinical management
clinical management and pharmacotherapy as usual for chronic dizziness
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Existing handicap due to dizziness (DHI equal to or more than 16)
* Written consent
Exclusion Criteria
* Vertigo/dizziness/unsteadiness explained by only organic cause or drug, diagnosed by neuro-otologist
* Physical status inappropriate for psychotherapy or vestibular rehabilitation
* Current psychiatric disorder other than anxiety disorders, somatic symptom disorder, or illness anxiety disorder (DSM-5), diagnosed by psychiatrist
* History of schizophrenia or bipolar disorder diagnosed by psychiatrist
* Increased risk of suicide or self-harm diagnosed by psychiatrist
* Started or increased SSRI/Venlafaxine within 1 month before treatment
* Any cognitive behavioral therapy or vestibular rehabilitation except this study
* Otological surgery or device therapy for dizziness
* Insufficient understanding of the Japanese language
20 Years
64 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nagoya City University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Masaki Kondo
MD, PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Masaki Kondo, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Nagoya City University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nagoya City University
Nagoya, Aichi-ken, Japan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.